Back
Adaptive Biotechnologies Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
63
ADPT
Adaptive Biotechnologies
Last Price:
$13.05
Seasonality Move:
-1.99%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ADPT is experiencing slight selling pressure.
Adaptive Biotechnologies Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.28 | Buy |
| 20-day SMA: | 11.23 | Buy |
| 50-day SMA: | 11.09 | Buy |
| 200-day SMA: | 8.22 | Buy |
| 8-day EMA: | 12.29 | Buy |
| 20-day EMA: | 11.65 | Buy |
| 50-day EMA: | 10.95 | Buy |
| 200-day EMA: | 8.63 | Buy |
Adaptive Biotechnologies Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.51 | Buy |
| Relative Strength Index (14 RSI): | 69.79 | Buy |
| Chaikin Money Flow: | -44178 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.34 - 12.1) | Buy |
| Bollinger Bands (100): | (8.15 - 11.33) | Buy |
Adaptive Biotechnologies Technical Analysis
| Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Adaptive Biotechnologies Stock
Is Adaptive Biotechnologies Stock a Buy?
-
Adaptive Biotechnologies share price is 12.92 while ADPT 8-day simple moving average is 12.28, which is a Buy signal.
-
The stock price of ADPT is 12.92 while Adaptive Biotechnologies 20-day SMA is 11.23, which makes it a Buy.
-
Adaptive Biotechnologies 50-day simple moving average is 11.09 while ADPT share price is 12.92, making it a Buy technically.
-
ADPT stock price is 12.92 and Adaptive Biotechnologies 200-day simple moving average is 8.22, creating a Buy signal.
ADPT Technical Analysis vs Fundamental Analysis
Buy
63
Adaptive Biotechnologies (ADPT)
is a Buy
Is Adaptive Biotechnologies a Buy or a Sell?
-
Adaptive Biotechnologies stock is rated a BuyThe current Adaptive Biotechnologies [ADPT] share price is $12.92. The Score for ADPT is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Adaptive Biotechnologies Stock Info
Market Cap:
2B
Price in USD:
12.92
Share Volume:
1.4M
Adaptive Biotechnologies 52-Week Range
52-Week High:
13.37
52-Week Low:
3.98
Buy
63
Adaptive Biotechnologies (ADPT)
is a Buy
Adaptive Biotechnologies Share Price Forecast
-
What is the Adaptive Biotechnologies stock price today?The Adaptive Biotechnologies stock price is 12.92 USD today.
-
Will ADPT stock go up or go down?Adaptive Biotechnologies> share price is forecast to RISE/FALL based on technical indicators
-
Is Adaptive Biotechnologies overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Adaptive Biotechnologies is not overvalued.
Is Adaptive Biotechnologies Stock a Buy?
-
Adaptive Biotechnologies share price is 12.92 while ADPT 8-day exponential moving average is 12.29, which is a Buy signal.
-
The stock price of ADPT is 12.92 while Adaptive Biotechnologies 20-day EMA is 11.65, which makes it a Buy.
-
Adaptive Biotechnologies 50-day exponential moving average is 10.95 while ADPT share price is 12.92, making it a Buy technically.
-
ADPT stock price is 12.92 and Adaptive Biotechnologies 200-day simple moving average is 8.63, creating a Buy signal.
Fundamental Analysis of Adaptive Biotechnologies
Is Adaptive Biotechnologies a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.05 per share, an increase this year of $0.34 per share, and an increase next year of $0.20 per share.
Technical Analysis of Adaptive Biotechnologies
Should I short Adaptive Biotechnologies stock?
-
ADPT Moving Average Covergence Divergence (MACD) indicator is 0.51, suggesting Adaptive Biotechnologies is a Buy
-
Adaptive Biotechnologies Relative Strength Index (RSI) is 69.79, which suggest Adaptive Biotechnologies is overbought
-
The Bollinger Bands (25) for Adaptive Biotechnologies is (10.34 - 12.1), which suggest Adaptive Biotechnologies is a Buy
-
The Bollinger Bands (100) for Adaptive Biotechnologies is (8.15 - 11.33), which suggest Adaptive Biotechnologies is a Buy
* Adaptive Biotechnologies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.